AboutMesothelioma.Net

NeoPlas Innovation, a clinical cancer treatment and research firm located in Nashville, Tennessee, has announced that a combination of the cholesterol medicine lovastatin and a low-dose of interferon has shown favorable results in fighting mesothelioma.

The patient was a woman who was exposed to asbestos in childhood. When she was diagnosed with mesothelioma, it had already filled most of the chest space where her right lung had been. According to NeoPlast, two months after starting treatments, a CT scan showed that the cancer had stabilized and the largest of the tumors had regressed significantly in size.

It’s still too early to draw full conclusions on the treatment because the testing is still in the early phases with only one patient so far.

NeoPlas is still accepting patients for the combination treatment.

For more breaking news on mesothelioma treatment, general information, and forum discussions, please visit Mesotheliomahelp.net.